Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Testosterone is important for male development and health, and careful replacement can treat low levels.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Certain genes may influence hair loss differently in men and women.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Infrared spectral imaging can effectively study protein distribution in hair follicles during hair growth.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

More research is needed to understand how testosterone is maintained in adult males.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Young men with male pattern baldness lose hair density over time without treatment.

Spironolactone helps regrow hair in women with hair loss.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride improves hair loss in women with hyperandrogenism.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

FUE hair transplantation using a micromotor is effective and gives natural results with few complications.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Minoxidil treatment can stimulate hair growth in hairless puppies if applied early.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Mesotherapy with natural extracts and vitamins can improve hair loss and promote regrowth in most women.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.